Clinical Trial Update: Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating cisplatin/etoposide with concurrent radiotherapy, with or without celecoxib, in unresectable locally advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Celecoxib (Celecoxib)
• Etoposide (Etoposide)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN